Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ESNT vs HLI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ESNT Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)

ESNT Overall Winner 6-Pillar Tally: ESNT 5 – 1 HLI Matrix Metrics: ESNT 8 – 2 HLI

As of Nov 16, 2026, Essent Group LTD (ESNT) is the stronger overall head-to-head candidate over Houlihan Lokey, Inc. (HLI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ESNT carries a Unified Composite Score of 46.4/100 (HOLD) at $65.23 (8.3x Forward P/E, 61.6% operating margin), whereas HLI carries 41.7/100 (SELL) at $141.37 (16.6x Forward P/E, 22.8% operating margin).

  • Technical & Structure Timing Caution: ESNT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.0); meanwhile HLI trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ESNT vs HLI
ESNT NYSE Head-to-Head Winner
Essent Group LTD
Surety Insurance
$65.23
+1.01% 1D
Market Cap $5.7B
TTM Revenue $1.39B
Forward P/E 8.3x
Beta / 30D Vol 0.04β · 38% Vol
Unified Composite Score
46.4 / 100 HOLD
Tech 30.0 Fund 46.0 Flow 55.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.6%) with fading momentum, RSI 49
RSI-14: 49.0 · SMA20: $66.14 · SMA50: $65.13
HLI NYSE
Houlihan Lokey, Inc.
Investment Advice
$141.37
-1.03% 1D
Market Cap $9.9B
TTM Revenue $2.56B
Forward P/E 16.6x
Beta / 30D Vol 0.70β · 41% Vol
Unified Composite Score
41.7 / 100 SELL
Tech 36.0 Fund 44.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (3.3% over 20 days), RSI 53
RSI-14: 53.0 · SMA20: $140.61 · SMA50: $134.28

6-Pillar Scorecard Institutional Category Breakdown (ESNT 5 – 1 HLI)

Columns: Metric · ESNT · HLI
1. Valuation Multiples ESNT
Forward P/E 8.3x 16.6x
Trailing P/E 8.8x 24.0x
PEG Ratio 0.84x 6.54x
EV / Revenue 4.3x 3.9x
2. Growth & Scale ESNT
Revenue Growth (YoY) +20.0% +4.8%
Earnings Growth (YoY) +9.0% +0.4%
TTM Revenue (USD) $1.39B $2.56B
Market Cap $5.7B $9.9B
3. Profitability & Quality ESNT
Gross Margin 72.8% 94.0%
Operating Margin 61.6% 22.8%
Net Profit Margin 49.1% 15.8%
Return on Equity (ROE) 12.0% 17.3%
4. Balance Sheet & Cash Flow ESNT
Cash Generation (TTM) $853M N/A
Cash Flow Margin 61.6% N/A
Net Cash / Leverage $336M Net Debt (0.09x D/E) $33.24 Book/Sh · 17.3% ROE
Dividend Yield 2.10% 1.81%
5. Options & Positioning ESNT
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 30.0% (3rd %ile) 26.0% (2nd %ile)
Put/Call OI Skew 2.20x (Put-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markup
6. R&D & Supply-Chain Moat HLI
OpEx & R&D Intensity 11.2% of Rev ($155M) 71.2% of Rev ($1.82B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role Insurance - Specialty Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ESNT (8) vs HLI (2)
Institutional Metric ESNT HLI Criterion Row Edge
Market Capitalization
Scale
$5.7B $9.9B Larger Scale HLI
Trailing P/E Ratio
Valuation
8.8x 24.0x Lower Multiple ESNT
Forward P/E Ratio
Valuation
8.3x 16.6x Lower Multiple ESNT
Revenue Growth (YoY)
Growth
+20.0% +4.8% Higher Growth ESNT
Operating Margin (TTM)
Profitability
61.6% 22.8% Higher Margin ESNT
Net Profit Margin
Profitability
49.1% 15.8% Higher Margin ESNT
Return on Equity (ROE)
Capital Efficiency
12.0% 17.3% Higher ROE HLI
52-Week Range Position
Momentum
60% ($55–$72) 35% ($113–$195) Stronger Trend ESNT
Beta / 30D Volatility
Risk Regime
0.04β · 38% Vol 0.70β · 41% Vol Lower Realized Risk ESNT
Unified Institutional Score
Composite Signal
46.4 / 100 (HOLD) 41.7 / 100 (SELL) Higher Composite ESNT
Trailing 12M Revenue (USD)
Operating Scale
$1.39B $2.56B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
72.8% 94.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.84x PEG · 4.3x EV/Rev 6.54x PEG · 3.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$853M ($336M Net Debt (0.09x D/E)) N/A ($33.24 Book/Sh · 17.3% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HLI +8.3 pp
ESNT: +0.82% · HLI: +9.12%
3M Horizon HLI +17.56 pp
ESNT: -6.25% · HLI: +11.31%
6M Horizon ESNT +12.13 pp
ESNT: +5.09% · HLI: -7.04%
1Y Horizon ESNT +28.19 pp
ESNT: +6.58% · HLI: -21.61%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ESNT vs HLI. Trailing 12-month operating profitability (ESNT 61.6% vs HLI 22.8%) and valuation multiples (ESNT 8.3x vs HLI 16.6x Forward P/E) are benchmarked directly in Pillar 4 below.

ESNT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.39B
Gross Margin72.8%
Op. Margin61.6%
ROE / Fwd P/E12.0% · 8.3x
HLI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.56B
Gross Margin94.0%
Op. Margin22.8%
ROE / Fwd P/E17.3% · 16.6x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ESNT CONSOLIDATION
65d in phase · OBV NEUTRAL
Current IV 30.0%
IV Percentile 3rd %ile
Put/Call OI Skew 2.20x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact ESNT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HLI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 26.0%
IV Percentile 2nd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HLI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ESNT Moat Profile High-Margin Pricing Power Moat
Insurance - Specialty Operator
Competes within the Insurance - Specialty value chain with $5.7B market capitalization and 61.6% operating margin.
OpEx & R&D Reinvestment 11.2% of Rev ($155M)
90D Engineering Disclosures 0 Published
HLI Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $9.9B market capitalization and 22.8% operating margin.
OpEx & R&D Reinvestment 71.2% of Rev ($1.82B)
90D Engineering Disclosures 0 Published

Investor FAQ ESNT vs HLI Key Questions & Quantitative Answers

As of Nov 16, 2026, Essent Group LTD (ESNT) is the stronger overall head-to-head candidate over Houlihan Lokey, Inc. (HLI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ESNT carries a Unified Composite Score of 46.4/100 (HOLD) at $65.23 (8.3x Forward P/E, 61.6% operating margin), whereas HLI carries 41.7/100 (SELL) at $141.37 (16.6x Forward P/E, 22.8% operating margin). Technical & Structure Timing Caution: ESNT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.0); meanwhile HLI trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ESNT leads the Growth & Scale pillar: ESNT posts +20.0% YoY revenue growth and +9.0% YoY earnings growth on $1.39B TTM revenue (72.8% gross margin, 61.6% operating margin), compared with HLI at +4.8% YoY revenue growth and +0.4% YoY earnings growth on $2.56B TTM revenue (94.0% gross margin, 22.8% operating margin). On trailing 12-month operating scale, ESNT generates $1.39B in USD-normalized revenue versus $2.56B for HLI. In operating R&D and SG&A reinvestment, ESNT deploys 11.2% of Rev ($155M) (0 90-day corporate R&D disclosures) versus 71.2% of Rev ($1.82B) (0 disclosures) for HLI.

ESNT screens cheaper on headline valuation multiples. ESNT trades at 8.3x Forward P/E, 8.8x Trailing P/E, 0.84x PEG, and 4.3x EV/Revenue (61.6% FCF margin), whereas HLI trades at 16.6x Forward P/E, 24.0x Trailing P/E, 6.54x PEG, and 3.9x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ESNT (12.0% ROE) versus HLI (17.3% ROE) capital efficiency.

In options market volatility and institutional positioning, ESNT carries 30.0% implied volatility (3rd %ile, Compressed (<25th %ile)), a 2.20x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.04β · 38% Vol realized risk). By comparison, HLI carries 26.0% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.70β · 41% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.